NK Cellular Therapeutics Labs
Dr. Jeff Miller's extraordinary success as a scientist and mentor has led to the creation of a consortium of laboratories, each run by an independent investigator, and each focused on some aspect of the very promising use of Natural Killer (NK) cells in the treatment of cancers and other chronic diseases. Our laboratory scientists do highly collaborative work in an effort to develop new and better immunologic therapies for blood-based and solid tumor malignancies.
Lab established 1993
Main research focus: Using transplantation of Natural Killer Cells to treat cancers
Lab established 2014
Main research focus: NK cell biology and hematopoietic cell transplantation
Lab established 2014
Main research focus: Cytokine signaling and development of NK-specific biologics
Lab established 2020
Main research focus: NK cells for use against myeloma
Assistant Professor
Akhilesh Kumar, PhD
Lab established 2022
Main research focus: Understanding hematopoietic development using human pluripotent stem cells (hPSCs) to develop novel-cell-based therapeutics
Lab established 2022
Main research focus: NK cells treating solid tumors
Assistant Professor
Pippa Kennedy, PhD
Lab established 2020
Main research focus: NK cell biology in organs and tumors
Lab established 2022
Main research focus: Mechanisms of NK cell target recognition